Zhulan Li

Title: Zhulan Li: Innovator in Pharmaceutical Composition

Introduction

Zhulan Li is a notable inventor based in Wuwei, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address bacterial infections. His innovative work focuses on enhancing the effectiveness of antibiotics through the use of natural extracts.

Latest Patents

Zhulan Li holds a patent for a pharmaceutical composition that includes honeysuckle extract and antibiotics. This composition is designed for the prevention and treatment of diseases caused by bacteria. The honeysuckle extract contains iridoid compounds, which, when combined with antibiotics, improve the responsiveness of multi-drug resistant bacteria. This advancement presents a promising clinical application, especially for treating refractory bacterial infections that are resistant to conventional antibiotics. The patent also includes a pharmaceutical kit that separates the honeysuckle extract and antibiotics for effective use.

Career Highlights

Zhulan Li is associated with Hankang Biochemical & Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has the potential to revolutionize how bacterial infections are treated, particularly in cases where traditional antibiotics fail.

Collaborations

Zhulan Li collaborates with esteemed colleagues such as Fengnian Han and Xuwei Ma. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Zhulan Li's contributions to pharmaceutical compositions highlight the importance of innovative approaches in combating bacterial resistance. His work not only enhances the effectiveness of existing treatments but also opens new avenues for drug development.